The global anticonvulsants market is growing as a result of a number of significant causes, including rising consumer knowledge of the anticonvulsants on the market and the patent expiration of numerous popular medications. In the US, the FDA has officially approved 24 Anticonvulsants Market for use in treating epilepsy. In addition, three developments regarding the use of AEDs have gained clinical significance and should be taken into account by everyone who treats patients with epilepsy.
Among these themes are concerns about AEDs being replaced by generic versions, pharmacogenomics' prediction of severe adverse events in specific ethnic populations, and the question of the suicide risk associated with the entire class of AEDs.
Read More @ https://cmiinfonest.blogspot.com/2022/09/the-global-anticonvulsants-market.html
